Share
  • LinkedIn
  • Facebook
  • X
  • Threads

IP Whiteboard

The final word and ‘smoking gun’ documents – ACCC v Pfizer

5 June 2018

For those readers interested in the issues surrounding competitive moves by pharmaceutical companies in the scenario where a key patent comes to an end, we report on the recent decision of the Full Federal Court in the ACCC v Pfizer matter here: ACCC v Pfizer – KWM News & Insights

Share
  • LinkedIn
  • Facebook
  • X
  • Threads

More Posts From This Author

Manner of manufacture and software-based inventions: Patent eligibility test re-affirmed but limited further clarity provided by Australian Appeals Court

18 September 2019
After much anticipation and a 10 month wait since the appeal was heard in November 2018, the expanded panel of five Federal Court judges in Encompass Pty Ltd v Infotrack Pty Ltd have delivered their decision, finding that they were “not persuaded that the primary judge erred in concluding that each [Encompass patent in suit] does not claim an invention that is a manner of manufacture within the meaning of section 6 of the Statute of Monopolies”.  Each of the Encompass patents in suit have accordingly been found to be invalid.
Read on

Australian company ordered to pay $10 million for unacceptable advertising claims: TGA uses its power to penalise inappropriate online advertisement and sale of therapeutic goods

2 August 2019
With increased internet penetration, the development of a myriad of mobile/ online applications for the delivery of digital health services that are expected to transform the way in which health care is provided and experienced, and the exponential growth in the number of e-commerce businesses vying for a share in the online retail space, there can be little doubt that the health care landscape is undergoing rapid change.
Read on